Standard long-acting insulin as good as newer m...( ugs on quality of life. The relative im...)

Standard long-acting insulin as good as newer medications

ugs on quality of life. The relative impact on long-term complications such as blindness or kidney failure also was not clear.

"For the patient the good news is that the older medication works very well," said John Buse, M.D., president-elect of the American Diabetes Association. "In most people it will lower blood sugar with little risk of hypoglycemia. The review also shows that Lantus and Levemir had fewer problems with low blood sugar at night, giving greater security for those who experience this while sleeping."

Weight gain when starting insulin treatment is a concern because it can cause some to quit taking the medications if they feel they are getting fat.

"Levemir has been shown to cause less weight gain than NPH in several studies," said Buse, who was not involved with the Cochrane review. Two review studies did find that patients treated with the newer drug gained up to 3.5 pounds less than those on NPH.

'"/>

Contact: Lisa Esposito
hbns-editor@cfah.org
Center for the Advancement of Health
17-Apr-2007

Page: 1 2
Related medicine news :

1. Standard developed for collection of suspicious powders
2. Standardized guidelines improve outcomes in stroke care
3. No benefit for liver cancer patients from long-acting octreotide
4. Exercise lowers insulin in breast cancer survivors
5. Study tests oral insulin to prevent type 1 diabetes
6. How insulin-producing cells develop -- new finding could help fight against diabetes
7. Low-glycemic load diet may be more effective for dieters with certain insulin response patterns
8. LAP-BAND System surgery improves insulin resistance
9. New project to analyze why Polycystic Ovary Syndrome and insulin resistance are so closely linked
10. Study tests oral insulin to prevent type 1 diabetes
11. Race may be risk factor for insulin resistance

Post Your Comments:

(Date:11/26/2009)...tions announces a highly effective and unconventio...g to make an economic recovery. , ... the type of challenge that could send ailing holi...David Benton, business growth expert and author of... The Rfactor Intensive . “Fear is one of ...

(Date:11/25/2009)...wswire/--WhenmostpeopleheartheacronymTMJ,theythink...thehelptheyneed.TMJstandsfortheTemporal-Mandibular...tswithyourskull(temporalbone). ,, Themostcommon...wing,clickingorpoppingofthejaw.Butmanyothersymptom...fatigue,sleepdisturbances,irritability,alossinfocu...

(Date:11/25/2009)...e-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: O...oreventsinDecember: ,, ASHBriefing ,, ...cipalinvestigatorswilldiscussdatapresentationssurr...lemyeloma,asfeaturedatthe51stAmericanSocietyofHema...LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m...

(Date:11/25/2009)...lleMedicalInc.,aleadingmanufacturerofbreastMRIcoil...ewleadingedgeclinicalapplicationsonitsAegis(TM)med...lSocietyofNorthAmerica(RSNA)annualmeetinginChicago...sleveragetheuniquehighqualityimagesgeneratedbySent...leimagingmodalitiesformulti-parametricassessment. ...

(Date:11/25/2009)...-USNewswire/--AnarticlebyJanetWoodcock,M.D.,direct...led"ADifficultBalance-PainManagement,DrugSafety,an...ndJournalofMedicine. ,, (Logo: http://www.newsc...article,WoodcockdiscussesFDAeffortstostrikeabalanc...managingtherisksposedbyvariousanalgesics.Asexample...

Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2 Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3

[0] Pharmacist Injects Cure for Ailing Businesses [1] TMJ and Chiropractic Care: An Overall Wellness Approach [0] Onyx Pharmaceuticals Announces December 2009 Investor Events [1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology [1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine

(Date:11/25/2009)..., EASTBRUNSWICK,N.J.,Nov.25/PRNewswire/--SwissrayI...alRadiography( ddR )systems,announcedtodaythatitso...thalongtermviewtowardsgrowingSwissray,smedicalimag...ctualproperty,aswellascontractsandinventory.After2...othenextleveloftechnologicaladvancementswithstable...

(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.comanno...atalogue: ,, PainManagement-GlobalTrends ,...agement---Global-Trends.html ,, Widespreadavai...inics,andtheadventofnewdrugshaveacceleratedthepace...sandreimbursementstructurecontinuetoshapedemandfor...

(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoC...atafromtheCompany,sPROTECT-1(theProspectiveRandomi...aficet-EN(TM)(CCX282-B)inpatientswithmoderate-to-s...hafavorablesafetyandtolerabilityprofile.Thestudyde...ofdiseaseseverityasdefinedasa70-pointdecreaseinthe...

Breaking Medicine Technology:Swissray International Announces New Ownership 2 Reportlinker Adds Pain Management - Global Trends 2 Reportlinker Adds Pain Management - Global Trends 3 Reportlinker Adds Pain Management - Global Trends 4 Reportlinker Adds Pain Management - Global Trends 5 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4 ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5 Questionnaire May Help Spot Early Dementia 48426 1 Questionnaire May Help Spot Early Dementia 48426 2 Questionnaire May Help Spot Early Dementia 48426 3 MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 1 MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 2 MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 3 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 1 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 2 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 3 ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer 48422 4

[0] Swissray International Announces New Ownership [0] Reportlinker Adds Pain Management - Global Trends [0] ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference

Other News:

... Chinese scientists from 30 institutes have gather... in the People's Republic of China to attend a six...e monitoring over China using ESA remote sensing i... Centre of China (NRSCC) are sponsoring the course...

Hamilton, ON - (Monday, Oct. 23, 2003) -- A national survey of Canadian surgeons by researchers at McMaster University found little consistency in their use of the blood thinner ASA in patients underg

...ple are among the populations at greatest risk for...ss index (BMI) and chronic disease may differ betw...sult, the World Health Organization has suggested ...rweight and obesity in Asian populations. ...Using...

New research suggests that statins can significantly reduce the incidence of stroke, myocardial infarction (MI), or all-cause death in patients with severe carotid arterial disease not revascularized.

health news:Dragon training in China focuses on atmosphere 2 health news:Dragon training in China focuses on atmosphere 3 health news:Dragon training in China focuses on atmosphere 4 health news:Should patients undergoing surgery get ASA? 2 health news:Statins reduce risk of stroke in heart patients 2

Dragon training in China focuses on atmosphere Should patients undergoing surgery get ASA?Obesity a growing problem in the Indo-Asian population Statins reduce risk of stroke in heart patients

... trouble talking to patients about psychotic sympt...chers analysed 32 consultations between psychiatri...tive disorder at two psychiatric outpatient clinic...y attempted to talk about the content of their psy...

...findings of a study in this week's issue of THE LA...part in the cellular processes involved in the dev...ncer is the second most frequent cause of death fr...s arise sporadically with no clear cause or geneti...

...lease is also available in French.......Vaccinatin...ims may be almost as effective as vaccinating the ...ientists have found. The study appears in the jour... for the Advancement of Science.......Using a comp...

...tlight Shines on Critical...Organ Donation and Tra... Quality Health Care (NCQHC) Assembles...Senior Th....NCQHC is sponsoring a national conference, Organ ...ity, with support from The Roche Foundation. .......

health news:Smallpox outbreak response: Targeted vaccination may be almost as effective as mass vaccination 2 health news:Smallpox outbreak response: Targeted vaccination may be almost as effective as mass vaccination 3

Doctors have trouble talking to patients about psychotic symptoms Human cytomegalovirus may be involved in colorectal cancer Smallpox outbreak response: Targeted vaccination may be almost as effective as mass vaccination National Conference on Organ Donation and Transplantation

Standard long-acting insulin as good as newer m...( ugs on quality of life. The relative im...),Health